---
schema_version: "secwatch.filing_event.v1"
accession: "0000785161-25-000028"
form_type: "8-K"
ticker: "EHC"
cik: "0000785161"
company_name: "Encompass Health Corp"
filed_at: "2025-06-03T23:59:59+00:00"
generated_at: "2026-05-20T02:13:03.194505+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Encompass Health reaffirms FY2025 guidance ahead of investor meetings

## Summary
- Reiterated FY2025 net operating revenue $5,850M-$5,925M.
- Adjusted EBITDA reaffirmed at $1,185M-$1,220M.
- Adjusted EPS from continuing ops reaffirmed at $4.85-$5.10.
- Senior management to meet investors on June 4 and June 18, 2025.

## SEC filing metadata
- accession: 0000785161-25-000028
- form_type: 8-K
- ticker: EHC
- cik: 0000785161
- company_name: Encompass Health Corp
- filed_at: 2025-06-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/785161/000078516125000028/0000785161-25-000028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/785161/000078516125000028/ehc-20250603.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000785161-25-000028
- JSON: https://secwatch.observer/filing/0000785161-25-000028.json
- Plain text: https://secwatch.observer/filing/0000785161-25-000028.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.